a public good project by the
Synthesis
Company
of California

© 2026

Tamio Fujiwara | doi.page

0 works0 citations0 h-index

Tamio Fujiwara

Shionogi (Japan)(JP)Futaba (Japan)(JP)

Publications by Year

Research Areas

HIV/AIDS drug development and treatment, HIV Research and Treatment, Biochemical and Molecular Research, Pneumocystis jirovecii pneumonia detection and treatment, HIV/AIDS Research and Interventions

Most-Cited Works

→ Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study(2014)499 cited
→ Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design(1999)493 cited
→ The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro(1990)408 cited
→ Retroviral DNA integration: Structure of an integration intermediate(1988)384 cited
→ In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor(2010)372 cited
→ Retroviral DNA Integration Directed by HIV Integration Protein in Vitro(1990)335 cited

→ Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study(2012)307 cited

→ Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers(2009)239 cited

→ Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir(2011)231 cited

→ Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults(2011)213 cited